It also addresses the FDA’s communications While using the applicant, the retention of records that assist the SE report, confidentiality of an SE report, how an applicant can amend or withdraw an SE report, how an applicant may possibly transfer ownership of the SE report to a fresh applicant and Digital submission with the SE report and amendme